Segment Data and Regional Results
Quarterly Statement Q1 2024
Q1 segment data — Chemicals
Million € |
2024 | 2023 | +/- |
| Sales to third parties | 2,764 | 2,833 | -2.4% |
of which Petrochemicals |
2,006 | 1,991 | 0.8% |
Intermediates |
758 | 842 | -10.0% |
EBITDA before special items |
453 | 426 | 6.2% |
| EBITDA |
453 | 425 | 6.6% |
| EBITDA margin before special items (%) |
16.4 | 15.1 | − |
| Depreciation and amortizationa | 200 | 185 | 7.9% |
| Income from operations (EBIT) | 253 | 240 | 5.5% |
| Special items | − | -1 | , |
| EBIT before special items | 253 | 241 | 4.9% |
| Investments including acquisitionsb | 560 | 382 | 46.4% |
| Segment cash flow | -556 | -187 | -197.8% |
| Assets (March 31) | 12,345 | 10,866 | 13.6% |
| Research and development expenses | 22 | 24 | -5.5% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q1 segment data — Materials
Million € |
2024 | 2023 | +/- |
| Sales to third parties | 3,441 | 3,844 | -10.5% |
of which Performance Materials |
1,758 | 1,950 | -9.8% |
Monomers |
1,682 | 1,894 | -11.2% |
EBITDA before special items |
508 | 448 | 13.5% |
| EBITDA |
549 | 451 | 21.8% |
| EBITDA margin before special items (%) |
14.8 | 11.7 | − |
| Depreciation and amortizationa | 204 | 205 | -0.6% |
| Income from operations (EBIT) | 346 | 246 | 40.6% |
| Special items | 34 | 3 | , |
| EBIT before special items | 311 | 243 | 28.2% |
| Investments including acquisitionsb | 292 | 197 | 48.3% |
| Segment cash flow | 85 | 111 | -23.0% |
| Assets (March 31) | 10,273 | 10,933 | -6.0% |
| Research and development expenses | 46 | 48 | -3.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q1 segment data — Industrial Solutions
Million € |
2024 | 2023 | +/- |
| Sales to third parties | 2,057 | 2,143 | -4.0% |
of which Dispersions & Resins |
1,275 | 1,308 | -2.5% |
Performance Chemicals |
782 | 835 | -6.4% |
EBITDA before special items |
332 | 300 | 10.6% |
| EBITDA |
330 | 292 | 13.3% |
| EBITDA margin before special items (%) |
16.1 | 14.0 | − |
| Depreciation and amortizationa | 84 | 95 | -11.1% |
| Income from operations (EBIT) | 246 | 197 | 25.0% |
| Special items | -2 | -19 | 91.9% |
| EBIT before special items | 248 | 216 | 14.6% |
| Investments including acquisitionsb | 47 | 53 | -10.5% |
| Segment cash flow | 59 | 148 | -60.2% |
| Assets (March 31) | 5,835 | 6,304 | -7.4% |
| Research and development expenses | 36 | 41 | -11.1% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Surface Technologies
Million € |
2024 | 2023 | +/- |
| Sales to third parties | 3,347 | 4,578 | -26.9% |
of which Catalysts |
2,314 | 3,539 | -34.6% |
Coatings |
1,033 | 1,039 | -0.6% |
EBITDA before special items |
356 | 402 | -11.6% |
| EBITDA |
327 | 369 | -11.5% |
| EBITDA margin before special items (%) |
10.6 | 8.8 | − |
| Depreciation and amortizationa | 145 | 139 | 4.3% |
| Income from operations (EBIT) | 182 | 230 | -21.1% |
| Special items | -29 | –33 | 13.1% |
| EBIT before special items | 211 | 263 | -20.1% |
| Investments including acquisitionsb | 94 | 103 | -8.9% |
| Segment cash flow | 292 | 307 | -5.0% |
| Assets (March 31) | 12,527 | 14,217 | -11.9% |
| Research and development expenses | 83 | 82 | 0.8% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q1 segment data — Nutrition & Care
Million € |
2024 | 2023 | +/- |
| Sales to third parties | 1,729 | 1,826 | -5.3% |
of which Care Chemicals |
1,217 | 1,300 | -6.4% |
Nutrition & Health |
512 | 525 | -2.6% |
EBITDA before special items |
262 | 192 | 36.8% |
| EBITDA |
261 | 190 | 37.0% |
| EBITDA margin before special items (%) |
15.2 | 10.5 | − |
| Depreciation and amortizationa | 131 | 110 | 19.1% |
| Income from operations (EBIT) | 130 | 80 | 61.4% |
| Special items | -1 | -1 | -8.3% |
| EBIT before special items | 131 | 82 | 60.6% |
| Investments including acquisitionsb | 138 | 143 | -3.6% |
| Segment cash flow | -64 | 3 | . |
| Assets (March 31) | 7,747 | 8,017 | -3.4% |
| Research and development expenses | 38 | 39 | -1.6% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q1 segment data — Agricultural Solutions
Million € |
2024 | 2023 | +/- |
| Sales to third parties | 3,478 | 3,891 | -10.6% |
| EBITDA before special items | 1,361 | 1,432 | -4.9% |
| EBITDA | 1,359 | 1,433 | -5.2% |
| EBITDA margin before special items (%) | 39.1 | 36.8 | − |
| Depreciation and amortizationa | 165 | 172 | -3.9% |
| Income from operations (EBIT) | 1,193 | 1,261 | -5.4% |
| Special items | -3 | 2 | , |
| EBIT before special items | 1,196 | 1,260 | -5.0% |
| Investments including acquisitionsb | 46 | 90 | -48.3% |
| Segment cash flow |
-715 | -758 | 5.7% |
| Assets (March 31) | 18,227 | 18,951 | -3.8% |
| Research and development expenses | 202 | 225 | -10.0% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q1 financial data — Other
| Million € | 2024 | 2023 | +/- |
Sales to third parties |
736 | 877 | -16.0% |
EBITDA before special items |
-560 | -336 | -66.9% |
of which costs for cross-divisional corporate research |
-53 | -59 | 9.3% |
costs of corporate headquarters |
–60 | –60 | 0.3% |
other businesses |
10 | 17 | -42.1% |
foreign currency results, hedging and other measurement effects |
-53 | -37 | -42.7% |
miscellaneous income and expenses |
-415 | -196 | -112.0% |
EBITDA |
-624 | -350 | -78.5% |
| Depreciation and amortizationa | 36 | 38 | -5.0% |
| Income from operations (EBIT) | -660 | -388 | -70.4% |
| Special items | -64 | -14 | -352.4% |
EBIT before special items |
-596 | -373 | -59.6% |
| Investments including acquisitionsb | 28 | 31 | -7.4% |
| Assets (March 31)c | 14,786 | 16,852 | -12.3% |
Research and development expenses |
61 | 79 | -22.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
c Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group
| Million € | Sales by location of company |
Sales by location of customer |
||||
|
2024 |
2023 |
+/– |
2024 |
2023 |
+/– |
Europe |
7,410 | 8,600 | -13.8% | 7,126 | 8,201 | -13.1% |
of which Germany |
2,940 | 3,372 | -12.8% | 1,682 | 2,002 | -16.0% |
North America |
5,375 | 5,933 | -9.4% | 5,232 | 5,921 | -11.7% |
| Asia Pacific | 3,830 | 4,455 | -14.0% | 3,924 | 4,514 | -13.1% |
of which Greater China |
2,102 | 2,309 | -9.0% | 2,072 | 2,275 | -8.9% |
South America, Africa, Middle East |
938 | 1,004 | -6.6% | 1,271 | 1,355 | -6.2% |
BASF Group |
17,553 | 19,991 | -12.2% | 17,553 | 19,991 | -12.2% |